Misovich, Stephen J.; Fisher, Jeffrey D.; Fisher, William A.
December 1999
Canadian Journal of Human Sexuality;Winter99, Vol. 8 Issue 4, p241
Academic Journal
The increasingly prevalent belief that HIV infection can now be cured through highly active antiretroviral therapy (HAART) regimens may contribute to elevated levels of HIV risk behaviours among HIV seropositive individuals. This study assessed the extent to which a sample of HIV seropositive men who have sex with men believed that HIV is now, or will soon, be curable. The association between respondents' degree of agreement with this belief their levels of HIV-risk behaviours (including unprotected insertive and receptive anal sex, and unprotected oral sex to ejaculation), and behavioural intentions regarding performing these behaviours, was assessed. Analyses indicated that belief in a cure for HIV was significantly, positively related to levels of risky behaviour and significantly positively related to levels of behavioural intentions to perform HIV risk behaviours in the future. As advanced treatments for HIV become more widespread, the potential exists for individuals to decide that HIV preventive behaviours may no longer be necessary. This new source of RN risk must be addressed through interventions designed to increase HIV+ individuals' awareness of the continuing dangers of unprotected sexual activity.


Related Articles

  • Rising prevalence of variant HIV-1 subtypes poses new diagnostic challenge. Robinson, John M. // MLO: Medical Laboratory Observer;Jul2007, Vol. 39 Issue 7, p28 

    The article focuses on the diagnostic challenge posed by the increasing prevalence of variant HIV-1 infection subtypes. Study shows that infections may represent up to 10 percent of HIV-1 infections in the U.S. They have significant implications for HIV- diagnostics and therapy. Another study...

  • Retroviral superinfection resistance. Nethe, Micha; Berkhout, Ben; Van der Kuyl, Antoinette C. // Retrovirology;2005, Vol. 2, p52 

    The retroviral phenomenon of superinfection resistance (SIR) defines an interference mechanism that is established after primary infection, preventing the infected cell from being superinfected by a similar type of virus. This review describes our present understanding of the underlying...

  • Treatment of Chronic Hepatitis B in the Human Immunodeficiency Virus--Infected Patient: Present and Future. Núñez, Marina; Puoti, Massimo; Camino, Nuria; Soriano, Vincent // Clinical Infectious Diseases;12/15/2003, Vol. 37 Issue 12, p1678 

    The management of chronic hepatitis B poses specific problems in the presence of human immunodeficiency virus (HIV) coinfection, because therapeutic approaches have to address both hepatitis B virus (HBV) and HIV infections. Response to interferon (IFN-α) is lower in HBV-HIV--coinfected than...

  • Researchers Devise Method for Natural Killer Cells to Destroy Hiding HIV.  // Ascribe Newswire: Medicine;5/19/2004, p141 

    Mayo Clinic researchers have identified a way to manipulate the body's own natural killer cells to destroy cells containing the HIV virus. Current treatments for HIV block the virus from replicating, but don't kill the cells that contain HIV. The existence of these HIV-harboring cells, often...

  • Adherence to Antiretroviral Therapy for Pediatric HIV Infection: Review of the Literature and Recommendations for Research. Steele, Ric G.; Grauer, Dennis // Clinical Child & Family Psychology Review;Mar2003, Vol. 6 Issue 1, p17 

    This review described and compared empirical investigations of adherence to pediatric antiretroviral therapy (ART) and predictors/correlates of adherence with regard to methodology and outcome. Thirteen empirical studies of children's adherence to ART, conducted between the years 1981 and 2002...

  • Long-term efficacy of darunavir/ritonavir monotherapy in patients with HIV-1 viral suppression: week 96 results from the MONOI ANRS 136 study. Valantin, M. A.; Lambert-Niclot, S.; Flandre, P.; Morand-Joubert, L.; Cabiè, A.; Meynard, J. L.; Ponscarme, D.; Ajana, F.; Slama, L.; Curjol, A.; Cuzin, L.; Schneider, L.; Taburet, A. M.; Marcelin, A. G.; Katlama, C. // Journal of Antimicrobial Chemotherapy (JAC);Mar2012, Vol. 67 Issue 3, p691 

    Objectives Long-term results at week 96 are needed to evaluate the capacity of the darunavir/ritonavir monotherapy strategy to maintain a sustained control of the HIV-1 viral load. Methods MONOI is a prospective, open-label, non-inferiority, randomized, 96 week trial comparing...

  • Viral and Latent Reservoir Persistence in HIV-1--Infected Patients on Therapy. Hwijin Kim; Perelson, Alan S. // PLoS Computational Biology;Oct2006, Vol. 2 Issue 10, p1232 

    Despite many years of potent antiretroviral therapy, latently infected cells and low levels of plasma virus have been found to persist in HIV-infected patients. The factors influencing this persistence and their relative contributions have not been fully elucidated and remain controversial....

  • Sharp fall in rates of second treatment failure and death after second failure.  // HIV Treatment ALERTS!;Apr2010, p32 

    The article discusses the study conducted in 1996 through 2005 regarding the rates of second treatment failure in people with HIV in the U.S. and Canada. It says that the study covers the assessment of HIV-infected people ages 18 above who underwent antiretroviral therapy wherein their first...

  • The Influence of HIV Infection on Clinical Presentation, Response to Treatment, and Outcome in Adults with Tuberculous Meningitis. Guy E. Thwaites; Nguyen Duc Bang; Nguyen Huy Dung; Hoang Thi Quy; Do Thi Tuong Oanh; Nguyen Thi Cam Thoa; Nguyen Quang Hien; Nguyen Tri Thuc; Nguyen Ngoc Hai; Nguyen Thi Ngoc Lan; Nguyen Ngoc Lan; Nguyen Hong Duc; Vu Ngoc Tuan; Cao Huu Hiep; Tran Thi Hong Chau; Pham Phuong Mai; Nguyen Thi Dung; Kasia Stepniewska; Cameron P. Simmons; Nicholas J. White // Journal of Infectious Diseases;12/15/2005, Vol. 192 Issue 12, p2134 

    Background. Tuberculous meningitis occurs more commonly in human immunodeficiency virus (HIV)-infected individuals than in HIV-uninfected individuals, but whether HIV infection alters the presentation and outcome of tuberculous meningitis is unknown. Methods. We performed a prospective...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics